2009
DOI: 10.1007/978-0-387-89072-2_5
|View full text |Cite
|
Sign up to set email alerts
|

Radiation Therapy in the Management of Retinoblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Contemporary retinoblastoma therapy is designed to avoid or delay the use of radiotherapy because it is reserved mainly as salvage therapy for patients whose eyes have failed chemotherapy or focal treatments . Moreover, the use of brachytherapy and more targeted external‐beam techniques have minimized radiation exposure to healthy orbital and nonorbital tissue, potentially decreasing the risk of complications such as radiation‐associated hearing loss or thyroid abnormalities . The use of focal therapies (eg, photocoagulation, cryotherapy), in conjunction with systemic chemotherapy has contributed to an overall decline in the number of enucleations performed in patients with unilateral disease, and has helped to preserve vision in a subset of patients with bilateral disease in whom 1 eye has the potential for vision .…”
mentioning
confidence: 99%
“…Contemporary retinoblastoma therapy is designed to avoid or delay the use of radiotherapy because it is reserved mainly as salvage therapy for patients whose eyes have failed chemotherapy or focal treatments . Moreover, the use of brachytherapy and more targeted external‐beam techniques have minimized radiation exposure to healthy orbital and nonorbital tissue, potentially decreasing the risk of complications such as radiation‐associated hearing loss or thyroid abnormalities . The use of focal therapies (eg, photocoagulation, cryotherapy), in conjunction with systemic chemotherapy has contributed to an overall decline in the number of enucleations performed in patients with unilateral disease, and has helped to preserve vision in a subset of patients with bilateral disease in whom 1 eye has the potential for vision .…”
mentioning
confidence: 99%